Chemed Corporation (CHE) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $376.41. It has a SharesGrow Score of 64/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of CHE = $1,124.11 (+198.6% from the current price, the stock appears undervalued). Analyst consensus target is CHE = $475 (+26.2% upside).
Valuation: CHE trades at a trailing Price-to-Earnings (P/E) of 20.5 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.78.
Financials: revenue is $2.5B, +5.8%/yr average growth. Net income is $265M, growing at +2.6%/yr. Net profit margin is 10.5% (healthy). Gross margin is 30% (-5.8 pp trend).
Balance sheet: total debt is $155M against $979M equity (Debt-to-Equity (D/E) ratio 0.16, conservative). Current ratio is 1.05 (adequate). Debt-to-assets is 9.4%. Total assets: $1.6B.
Analyst outlook: 4 / 9 analysts rate CHE as buy (44%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 66/100 (Pass), Growth 55/100 (Partial), Past 100/100 (Pass), Health 83/100 (Pass), Moat 45/100 (Partial), Future 46/100 (Partial), Income 55/100 (Partial).
